Resonance Specialties Ltd
Fundamental Score
Resonance Specialties Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of RESONANCE across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (15.40%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (15.87%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 15.24 vs Industry: 29.20)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Strong Revenue Growth (19.21%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Conservative Debt Levels (D/E: 0.04)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (38.57x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (54.25%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Weak Earnings Growth (1.29% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (1.29% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Negative Free Cash Flow (₹-3.15 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 0.03%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Resonance Specialties Ltd
About RESONANCE
Business Overview
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, pyrazinamide and isoniazid; alpha picolinic and dipicolinic acids; solvents comprising acetonitrile and valeronitrile; and lutidines and collidines for anti-ulcer drugs. The company was formerly known as Armour Polymers Limited. Resonance Specialties Limited was incorporated in 1989 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
Latest News
RESONANCE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Resonance Specialties Ltd (RESONANCE)?
As of 21 Jan 2026, 08:48 am IST, Resonance Specialties Ltd (RESONANCE) is currently trading at ₹96.05. The stock has a market capitalization of ₹113.97 (Cr).
Is RESONANCE share price Overvalued or Undervalued?
RESONANCE is currently trading at a P/E ratio of 15.24x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Resonance Specialties Ltd share price?
Key factors influencing RESONANCE's price include its quarterly earnings growth (Sales Growth: 19.21%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Resonance Specialties Ltd a good stock for long-term investment?
Resonance Specialties Ltd shows a 5-year Profit Growth of 1.29% and an ROE of 11.65%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.04 before investing.
How does Resonance Specialties Ltd compare with its industry peers?
Resonance Specialties Ltd competes with major peers in the Specialty Chemicals. Investors should compare RESONANCE's P/E of 15.24x and ROE of 11.65% against the industry averages to determine its competitive standing.
What is the P/E ratio of RESONANCE and what does it mean?
RESONANCE has a P/E ratio of 15.24x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹15 for every ₹1 of annual earnings.
How is RESONANCE performing according to Bull Run's analysis?
RESONANCE has a Bull Run fundamental score of 43.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does RESONANCE belong to?
RESONANCE operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Resonance Specialties Ltd.
What is Return on Equity (ROE) and why is it important for RESONANCE?
RESONANCE has an ROE of 11.65%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Resonance Specialties Ltd generates profits from shareholders' equity.
How is RESONANCE's debt-to-equity ratio and what does it indicate?
RESONANCE has a debt-to-equity ratio of 0.04, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is RESONANCE's dividend yield and is it a good dividend stock?
RESONANCE offers a dividend yield of 1.01%, which means you receive ₹1.01 annual dividend for every ₹100 invested.
How has RESONANCE grown over the past 5 years?
RESONANCE has achieved 5-year growth rates of: Sales Growth 6.75%, Profit Growth 1.29%, and EPS Growth 1.29%.
What is the promoter holding in RESONANCE and why does it matter?
Promoters hold 54.25% of RESONANCE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is RESONANCE's market capitalization category?
RESONANCE has a market capitalization of ₹114 crores, placing it in the Small-cap category.
How volatile is RESONANCE stock?
RESONANCE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for RESONANCE?
RESONANCE has a 52-week high of ₹N/A and low of ₹N/A.
What is RESONANCE's operating profit margin trend?
RESONANCE has a 5-year average Operating Profit Margin (OPM) of 15.87%, indicating the company's operational efficiency.
How is RESONANCE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 19.21% and YoY Profit Growth of -3.49%.
What is the institutional holding pattern in RESONANCE?
RESONANCE has FII holding of 0.00% and DII holding of 0.03%. Significant institutional holding often suggests professional confidence in the stock.